Product Information

LAMIVUDINE 150 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.4685 per EA under NDC 33342000109. Its NADAC has been published 333 times since Feb 12, 2020.

FDA first approved this application on May 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LAMIVUDINE 150 MG TABLET

Lamivudine
$0.4685per EA

Strength

150 mg/1

NDC

33342000109

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LAMIVUDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA090198

FDA Approved

5/1/2019

TE Code

AB

On Market Since

5/2/2019

Price Statistics

The NADAC for LAMIVUDINE 150 MG TABLET has been published 333 times since Feb 12, 2020, and over the history we have for it it has declined 49.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4685 per EA
All-time high$1.2132 (Jan 13, 2021)
All-time low$0.4126 (Oct 22, 2025)
52-week high$0.4887
52-week low$0.4254
Median price$0.8475
Average price$0.7413
Largest weekly change-47.9% (Apr 17, 2024)
Weeks tracked333
Tracking sinceFeb 12, 2020

Price History

1W

-2.4%

1M

-4.1%

3M

-4.1%

6M

+4.4%

1Y

+9.7%

3Y

-44.7%

5Y

-51.6%

All

-49.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LAMIVUDINE 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 150 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.4685 per EA (NDC 33342000109), effective Nov 18, 2026.

How has the price of LAMIVUDINE 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMIVUDINE 150 MG TABLET has declined 49.7%. It has been tracked across 333 weekly CMS publications since Feb 12, 2020.

What are the highest and lowest recorded NADAC prices for LAMIVUDINE 150 MG TABLET?

Since Feb 12, 2020, the NADAC for LAMIVUDINE 150 MG TABLET has ranged from a low of $0.4126 (Oct 22, 2025) to a high of $1.2132 (Jan 13, 2021), with a median of $0.8475 per EA.

Are there cheaper alternatives to LAMIVUDINE 150 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LAMIVUDINE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LAMIVUDINE 150 MG TABLET?

LAMIVUDINE 150 MG TABLET (NDC 33342000109) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.